CTT PHARMACEUTICAL HOLDINGS, INC. purchased $518 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 11,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.04 on 2026-08-20.
How this was made
The 30-second read
Why it matters
The filing provides a fresh data point on insider activity but the modest size limits trading relevance.
Market read
Primary insider purchase disclosed; low materiality.
What to watch
CEO's existing large stake may dilute the significance of this incremental buy.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals.
Ticker impact
CEO purchased 11,500 shares for $517.50 in a Form 4 filing.
Limited short-term impact; may provide slight bullish bias.
The transaction is a primary disclosure but the dollar amount is trivial, so market reaction is expected to be muted.
Market effects
Minimal effect on the pharmaceutical sector.
None
None
Counterpoint
The small purchase could be a routine portfolio rebalancing, not a strong endorsement.
Key entities
- CompanyCTT Pharmaceutical Holdings, Inc.
Issuer of the Form 4 filing.
- IndividualCEO (unnamed)
Insider executing the purchase.